Direct comparison of JADAS-71 and JADAS3-71 values at first presentation to paediatric rheumatology in the 352 patients with JADAS available
| Whole cohort | Systemic | Persistent oliogarthritis | Extended oligoarthritis | RF (−) polyarthritis | RF (+) polyarthritis | Enthesitis related | Psoriatic arthritis | Undifferentiated | p Value* | |
|---|---|---|---|---|---|---|---|---|---|---|
| N | 352 | 28 | 164 | 13 | 67 | 11 | 16 | 28 | 25 | |
| JADAS | ||||||||||
| JADAS-71 | 11 (5.9–18) | 19.6 (15.6–26) | 7.5 (4.2–11.3) | 13.5 (4.5–21.3) | 20 (13.5–25) | 16.6 (7.6–51.5) | 10 (5.1–16.6) | 12.6 (9.4–23.3) | 9 (5.7–20.2) | 0.0001 |
| JADAS-27 | 10.4 (5.7–17) | 19.6 (14.7–24) | 7.5 (4.1–11.1) | 13.2 (4.5–19.3) | 18.9 (11.9–24.1) | 14.6 (7.6–38.6) | 10 (5.1–15) | 11.6 (8.1–20) | 9.1 (5.7–20.2) | 0.0001 |
| JADAS-10 | 11 (5.9–17.3) | 19.6 (15.6–25.1) | 7.5 (4.2–11.3) | 13.5 (4.5–19.7) | 18.6 (13–22.5) | 16.6 (7.6–25.2) | 10.2 (5.1–16.6) | 12.6 (9.4–18.2) | 9.1 (5.7–20.2) | 0.0001 |
| JADAS3 | ||||||||||
| JADAS3-71 | 9.5 (5.2–14.9) | 12.5 (9.7–17.6) | 6.7 (3.8–10.4) | 13.5 (2.2–19.2) | 16.5 (12.4–21.6) | 15.5 (7.6–42.5) | 9.5 (4.5–13.7) | 11.1 (8–22.1) | 8 (5.7–16.7) | 0.0001 |
| JADAS3-27 | 9.4 (5–14.4) | 12 (9.7–17.1) | 6.7 (3.7–9.5) | 12.9 (2.2–18.2) | 15.3 (11.4–20.5) | 14.5 (7.6–37.3) | 9.5 (4.5–12.3) | 10.2 (6.5–17.9) | 7.6 (5.7–15) | 0.0001 |
| JADAS3-10 | 9.5 (5.2–14.6) | 12.5 (9.7–17.6) | 6.7 (3.8–10.4) | 13.5 (2.2–17.3) | 15.7 (12.4–18.6) | 15.5 (7.6–21.6) | 9.5 (4.5–14.2) | 11.1 (8–16.6) | 8 (5.7–16.7) | 0.0001 |
Values aremedian (IQR).
*Kruskal–Wallis test.
JADAS, Juvenile Arthritis Disease Activity Score; RF, rheumatoid factor.